2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow Myalgic Encephalomyelitis: new trials by email Literature Review of Myalgic Encephalomyelitis trials Research Report on Myalgic Encephalomyelitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome Etanercept - Chronic Fatigue Syndrome, Myalgic Encephalomyelitis | Phase 2 | Terminated | Haukeland University Hospital | 4 | 2012-10-01 | 2015-12-02 |
| B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Very Severe Chronic Fatigue Syndrome Rituximab - Chronic Fatigue Syndrome, Myalgic Encephalomyelitis | Phase 2 | Terminated | Haukeland University Hospital | 8 | 2010-06-01 | 2024-03-04 |
Chronic Disease (2) · Disease Attributes (2) · Encephalomyelitis (2) · Muscular Diseases (2) · Musculoskeletal Diseases (2) · Nervous System Diseases (2) · Neuroinflammatory Diseases (2) · Neuromuscular Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2)
Etanercept (1) · Rituximab (1)
Haukeland University Hospital (2)
Norway (2)